Abe A, Furumoto H, Yoshida K, Nishimura M, Irahara M, Kudo E, Sano T
Department of Obstetrics and Gynecology, School of Medicine University of Tokushima, Tokushima, Japan.
Int J Gynecol Cancer. 2008 Jan-Feb;18(1):168-72. doi: 10.1111/j.1525-1438.2007.00952.x. Epub 2007 Apr 26.
Endometrioid adenocarcinoma of the ovary coexists very rarely with yolk sac tumor (YST). This unusual mixed tumor is thought to be a rare variant of endometrioid ovarian carcinoma because of its aggressive behavior, lack of response to chemotherapy, and unfavorable prognosis. We report a case of ovarian endometrioid adenocarcinoma with a YST component in a postmenopausal woman. The patient was treated by surgery and a combination of bleomycin, etoposide, and cisplatin and taxol and carboplatin. She has been clinically free of tumor for 20 months. Immunohistochemically, the YST component reacted for alpha-fetoprotein. YST areas were negative for both CA125 and sex-hormone receptors. Cytokeratin7 and epithelial membrane antigen were negative in YST, but positive in endometrioid adenocarcinoma. The occurrence of this unusual case suggests that even somatic carcinomas may acquire an extraembryonal germ cell differentiation.
卵巢子宫内膜样腺癌极少与卵黄囊瘤(YST)共存。这种不寻常的混合性肿瘤因其侵袭性、对化疗无反应以及预后不良,被认为是子宫内膜样卵巢癌的一种罕见变体。我们报告一例绝经后女性患有含YST成分的卵巢子宫内膜样腺癌。该患者接受了手术治疗,并联合使用了博来霉素、依托泊苷和顺铂以及紫杉醇和卡铂。她已临床无瘤20个月。免疫组化显示,YST成分甲胎蛋白呈阳性反应。YST区域CA125和性激素受体均为阴性。细胞角蛋白7和上皮膜抗原在YST中为阴性,但在子宫内膜样腺癌中为阳性。这一罕见病例的出现表明,即使是体细胞癌也可能获得胚胎外生殖细胞分化。